Pfizer, BioNTech begin omicron-specific COVID-19 vaccine study
January 25, 2022 at 08:36 AM EST
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
